Negative symptoms – how to diagnose and treat them?

Prof. Dr. Dr. hc mult. Hans-Jürgen Möller, Department of Psychiatry, Ludwig-Maximilians-University (Germany)
 
Hans-Jürgen Möller, MD, worked from 1988 to 1994 as full Professor of Psychiatry and Chairman of the Psychiatric Department at the University of Bonn (Germany) and from 1994 to 2012 as full Professor of Psychiatry and Chairman of the Psychiatric Department at the Ludwig-Maximilians-University in Munich (Germany), where he acts now as professor emeritus. Professor Möller’s main scientific contributions include clinical and neurobiological research into psychiatry, schizophrenia and depression, and clinical psychopharmacology. Professor Möller has written and co-authored over 1,300 scientific publications (Hirsch Factor 120) and several books. He was certified 2014 and 2015 by Thomson Reuters among 1% of researches for most cited papers (2002-2012). He was editor or co-editor of several German or English journals like “European Archives of Psychiatry and Clinical Neuroscience”,  “World Journal of Biological Psychiatry”. He was President of the World Federation of Society of Biological Psychiatry (WFSBP), of the European Psychiatric Association (EPA) and Chairman of the Section on Pharmacopsychiatry of the World Psychiatric Association (WPA). He is Past-President of the Collegium Internationale Neuro-Psychopharmacologicum (CINP).
 
“Negative symptoms are an important and clinically relevant dimension of schizophrenic patients. They have been associated with detrimental effects on patients’ functional status and quality of life and long-term outcome. The detection and diagnosis of negative symptoms can be difficult not only because their c1inical expression is less obvious than that of positive symptoms, but also because negative symptoms can be masked by positive symptoms and can coexist with or be confused with affective symptoms or cognitive impairment. Treatment can also be difficult, because none of the available antipsychotic medications has been consistently and reliably effective in controlling negative symptoms, and other medications do not seem to have adequate efficacy. Thus negative symptoms belong to the most relevant unmet needs in schizophrenia treatment. There is hope that the management of negative symptoms might become easier through improved clinical assessment procedures, a better neurobiological understanding and the development of new, effective pharmacological treatments.”

Related posts

27 April 2020

New Reality. How COVID-19 is changing the work of Russian NGOs

Survey by CAF

11 July 2022

News from the winners of the I All-Russian contest of research papers on mental health for students of medical and non-medical universities

A study to identify the psychological causes of eating disorders in people was held in the Togliatti State University. Its...

5 August 2021

Youth & Mental Health: Challenges Ahead

Rakesh Chadda, MD, Secretary General of the World Association for Social Psychiatry, Professor and Head of the Department of Psychiatry,...

11 January 2017

Have you said Thank You today?

Gracias. Danke. Grazie. Asante. Sukria. Thank you… This simple phrase in English and its variant in all languages of the...

24 January 2017

8th World Congress for Psychotherapy

“Conflicts arise in the human mind and it is in the human mind that they can be resolved.” Acceptance speech...

7 April 2020

7 APRIL 2020 - WORLD HEALTH DAY

7 April 2020 is the day to celebrate the work of nurses and midwives and remind world leaders of the...

5 December 2017

5 December - The International Volunteer Day

The International Volunteer Day (IVD) mandated by the UN General Assembly, is held each year on 5 December. It is viewed...

16 August 2017

NEW E-LEARNING PLATFORM – OpenWHO

Source: https://openwho.org World Health Organization (WHO) launches a new e-learning platform, OpenWHO, with video courses on epidemics, pandemics and health emergencies. OpenWHO...

3 October 2018

Welcome Address from WHO

Dr. Svetlana Akselrod, Assistant Director-General of WHO for Noncommunicable Diseases and Mental Health

26 July 2016

Prof. Roy Abraham Kallivayalil, WPA Secretary General, Vice-Principal, Professor&Head, Dept. of Psychiatry at Pushpagiri Institute of Medical Sciences (Tiruvalla, Kerala), will take part in the Congress

Prof. Roy Abraham Kallivayalil, Secretary General of the World Psychiatric Association, Vice-Principal, Professor&Head, Dept. of Psychiatry at Pushpagiri Institute of Medical Sciences...